← Back to Search

Managed Problem Solving for HIV/AIDS Care

N/A
Recruiting
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
age 18 or older
A man or woman living with HIV
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a behavior change intervention delivered by community health workers to improve viral suppression and care retention in people living with HIV.

Who is the study for?
This trial is for adults living with HIV who are not consistently in care or have not achieved viral suppression. It's specifically designed to help those who may benefit from additional support by Community Health Workers.
What is being tested?
The trial tests a behavioral intervention called Managed Problem Solving (MAPS+), delivered by Community Health Workers, aimed at improving medication adherence and retention in HIV care. The effectiveness of MAPS+ will be compared to usual care across several clinics.
What are the potential side effects?
Since MAPS+ is a behavioral intervention rather than a medical treatment, it does not have traditional side effects like drugs do. However, participants might experience stress or discomfort discussing personal issues during the problem-solving sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am living with HIV.
Select...
I am 18 years old or older.
Select...
I am living with HIV.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Undetectable HIV viral load (<20 copies/ml)
Secondary study objectives
Adherence to HIV therapy
CD4 Count
Retention in care

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MAPS+Experimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,726,268 Total Patients Enrolled

Media Library

Managed Problem Solving (MAPS) Clinical Trial Eligibility Overview. Trial Name: NCT04560621 — N/A
HIV/AIDS Research Study Groups: MAPS+, Standard of Care
HIV/AIDS Clinical Trial 2023: Managed Problem Solving (MAPS) Highlights & Side Effects. Trial Name: NCT04560621 — N/A
Managed Problem Solving (MAPS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04560621 — N/A
~97 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top